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Summary
A	total	of	1,995	pigs	were	used	to	evaluate	the	effects	of	two	porcine	circovirus	type	
2	(PCV2)	and	Mycoplasma hyopneumoniae	(Mhyo)	vaccination	strategies	and	birth	
weight	on	pig	performance	and	carcass	characteristics.	The	first	vaccination	strategy	
(BI)	was	a	single	full	dose	of	CircoFLEX-MycoFLEX	(Boehringer	Ingelheim,	St.	
Joseph,	MO)	at	weaning.	The	second	strategy	(Intervet)	was	a	full	dose	of	Circumvent	
and	MYCOSILENCER	(Intervet/Schering-Plough	Animal	Health,	Millsboro,	DE)	
at	weaning	and	again	22	d	later.	At	a	commercial	sow	farm,	all	pigs	born	alive	for	22	
consecutive	days	were	identified	individually	at	birth	with	a	numbered	ear	tag.	The	dam,	
gender,	and	birth	weight	were	recorded	and	used	to	randomly	allot	pigs	at	weaning		
(d	0)	to	the	PCV2/Mhyo	vaccination	treatments.	The	pigs	were	weaned	into	4	consecu-
tive	nursery	rooms	of	approximately	500	pigs	each	on	6	occasions	during	a	19-d	period.	
Pigs	from	each	vaccination	treatment	were	comingled	in	pens	within	rooms	throughout	
the	study.	Pigs	were	moved	to	a	finishing	barn	on	d	74.	Pigs	were	individually	weighed	
on	d	0,	22,	44,	74,	and	156	to	measure	growth	rate.	Carcass	data	were	obtained	from	a	
subsample	of	420	pigs	harvested	on	a	single	day	(d	167).	For	data	analysis,	individual	
birth	weight	was	used	to	assign	pigs	to	7	birth	weight	categories,	each	containing	a	
similar	number	of	observations.	Therefore,	data	were	analyzed	as	a	2	×	2	×	7	factorial	
arrangement	in	a	completely	randomized	design	with	main	effects	of	vaccine	strategy,	
gender,	and	weight	category.	As	birth	weight	category	increased,	ADG	increased		
(P	<	0.01)	during	each	weight	period	and	overall.	Percentage	of	culls	and	light	weight	
pigs	at	market	also	were	reduced	(P	<	0.01)	as	weight	category	increased.	Overall,	ADG,	
final	BW,	HCW,	and	backfat	depth	of	barrows	were	increased	(P	<	0.0001)	compared	
with	gilts,	whereas	the	percentage	of	culls	and	pigs	<	215	lb	and	fat-free	lean	were	
reduced	(P	<	0.0001)	compared	with	gilts.	
From	d	0	to	22	and	d	44	to	74,	vaccine	strategy	did	not	influence	ADG.	However,	
ADG	and	BW	were	greater	(P	<	0.05)	from	d	22	to	44	for	pigs	vaccinated	once	with	BI	
rather	than	twice	with	Intervet.	From	d	74	to	156,	pigs	vaccinated	twice	with	Intervet	
had	greater	(P	<	0.05)	ADG	than	those	vaccinated	once	with	BI.	Thus,	there	were	no	
differences	between	the	2	vaccination	strategies	for	overall	growth	performance,	carcass	
measurements,	or	mortality.	These	results	are	similar	to	those	of	previous	experiments	
that	demonstrated	that	vaccination	with	Intervet	reduced	performance	in	the	nursery	
stage	but	improved	performance	in	the	finisher	stage.	In	summary,	vaccination	strategy,	
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piglet	birth	weight,	and	gender	all	influence	the	growth	of	pigs	during	the	nursery	stage,	
finishing	stage,	and	overall	and	should	be	considered	to	enhance	overall	performance.
Key	words:	birth	weight,	gender,	growth,	PCV2,	vaccination
Introduction
Porcine	circoviral	disease	(PCVD)	clinical	signs	include	one	or	more	of	the	following	in	
growing	pigs:	wasting,	labored	breathing,	diarrhea,	porcine	dermatitis	and	nephropathy	
syndrome,	secondary	bacterial	infections,	and	high	mortality.	Porcine	circoviral	disease	
is	caused	by	infection	with	porcine	circovirus	type	2	(PCV2).	Recent	studies	(Jacela	
et	al.,	20073;	Horlen	et	al.,	20084)	have	demonstrated	that	the	subclinical	manifesta-
tion	of	this	organism	in	unvaccinated	pigs	is	also	associated	with	significant	reductions	
in	performance	of	growing-finishing	pigs.	For	this	reason,	many	swine	producers	are	
currently	vaccinating	growing	pigs	for	PCV2	with	one	of	the	commercially	available	
vaccines.
Although	improvements	in	the	health	and	performance	of	growing-finishing	pigs	have	
been	observed	with	the	implementation	of	PCV2	vaccination	in	the	field,	some	produc-
ers	have	experienced	increased	difficulty	in	getting	pigs	started	on	feed	after	weaning.	
In	most	of	these	cases,	pigs	have	been	vaccinated	for	PCV2	and	Mycoplasma hyopneu-
moniae	(Mhyo)	at	weaning.	Recent	work	at	Kansas	State	University	(K-State;	Kane	et	
al.,	20085)	suggests	that	vaccination	of	pigs	for	PCV2	and	Mhyo	at	the	recommended	
ages	may	be	followed	by	a	transient	reduction	in	nursery	performance.
Little	work	has	been	done	to	determine	whether	this	transient	reduction	is	character-
istic	of	all	commercially	available	PCV2	and	Mhyo	vaccines	or	vaccination	strategies.	
Jacela	et	al.	(2007)	reported	that	pigs	vaccinated	with	2	doses	(d	0	and	21)	of	one	PCV2	
vaccine	were	heavier	than	unvaccinated	pigs	at	d	113,	with	pigs	vaccinated	with	1	dose	
(d	7)	of	a	second	PCV2	vaccine	being	intermediate.	They	reported	that	the	benefits	to	
growth	from	PCV2	vaccination	occurred	primarily	during	the	first	113	d	and	did	not	
observe	any	transient	reductions	in	performance	after	vaccination.	However,	the	post-
vaccination	weighing	events	occurred	at	lengthy	intervals.
Other	factors	are	known	to	influence	the	growth	performance	of	pigs	immediately	
postweaning,	including	management,	genetics,	health,	nutrition,	environment,	gender,	
weaning	age,	and	weaning	weight.	Many	farms	have	demonstrated	acceptable	levels	
of	nursery	performance	prior	to	the	implementation	of	PCV2	vaccination.	However,	
since	the	implementation	of	PCV2	vaccinations,	some	of	these	farms	have	reported	an	
unacceptable	number	of	pigs	that	appeared	normal	at	weaning	but	began	a	progressive	
decline	in	body	condition	within	the	first	5	d	postweaning.	These	“failure-to-thrive”	
pigs	appeared	to	remain	hydrated	and	alert	with	normal	vital	signs	but	did	not	respond	
to	individualized	environmental,	nutritional,	and	antimicrobial	interventions.	They	
continued	to	progressively	catabolize	fat	and	muscle	tissue	to	the	point	that	eutha-
nasia	was	the	only	remaining	humane	resolution.	In	these	populations	of	pigs,	it	has	
3	Jacela	et	al.,	Swine	Day	2007,	Report	of	Progress	985,	pp.	5-16.
4	Horlen,	K.	P.,	S.	S.	Dritz,	J.	C.	Nietfeld,	S.	C.	Henry,	R.	A.	Hesse,	R.	Oberst,	M.	Hays,	J.	Anderson,	
and	R.	R.	R.	Rowland.	2008.	A	field	evaluation	of	pig	mortality,	performance	and	infection	following	
commercial	vaccination	against	porcine	circovirus	type	2.	J.	Am.	Vet.	Med.	Assoc.	232:906-912.
5	Kane	et	al.,	Swine	Day	2008,	Report	of	Progress	1001,	pp.	14-20.
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been	difficult	to	identify	the	individual	characteristics	that	may	be	associated	with	an	
increased	risk	for	becoming	a	“failure-to-thrive”	pig.
Therefore,	our	objective	was	to	compare	the	effects	of	2	vaccination	strategies	for	miti-
gating	the	effects	of	PCV2	and	Mhyo	on	postweaning	performance.	A	second	objective	
was	to	evaluate	the	combined	effects	of	PCV2	vaccination	strategy,	birth	weight,	and	
gender	on	individual	pig	performance	postweaning.
Procedures
Procedures	used	in	this	experiment	were	approved	by	the	K-State	Institutional	Animal	
Care	and	Use	Committee.	The	experiment	was	conducted	at	a	commercial	farm	in	
Kansas	with	a	segregated,	3-site	production	system	(breeding/gestation/farrowing,	
nursery,	and	finisher).	This	experiment	used	908	pigs	(PIC	327	sired)	born	of	first,	
second,	and	a	few	third	parity	females	(Triumph	TR24)	and	1,047	pigs	(PIC	327	sired)	
born	of	third	parity	and	older	sows	(PIC	1050).	All	pigs	were	housed	in	environmen-
tally	controlled	buildings	with	pens	over	totally	slatted	floors	throughout	the	experi-
ment.
During	lactation,	sows	and	their	litters	were	housed	in	farrowing	crates	and	given	ad	
libitum	access	to	food	and	water.	For	22	consecutive	days,	all	pigs	born	alive	were	iden-
tified	with	a	small	numbered	button	ear	tag,	and	their	weight	and	gender	were	recorded	
within	18	h	after	parturition.	Afterward,	litters	were	equalized	and	processed	following	
normal	farm	procedures	to	optimize	sow	and	piglet	health	and	welfare.	Every	attempt	
was	made	to	keep	subsequent	pig	movement	at	a	minimum;	however,	all	necessary	pig	
movement,	fostering,	removals,	and	mortalities	were	recorded.	None	of	the	pigs	were	
given	access	to	creep	feed	or	additional	supplements	during	lactation.
A	total	of	1,995	pigs	were	weaned	(16.4	lb	and	25	d	of	age)	in	6	groups	of	approxi-
mately	330	to	340	pigs	to	fill	four	500-head	rooms	over	a	19-d	period.	Prior	to	each	
weaning	event,	pigs	scheduled	to	be	weaned	were	allotted	to	one	of	2	vaccination	strate-
gies	stratified	by	dam,	gender,	and	birth	weight.	One	vaccination	strategy	consisted	of	a	
single	full	dose	of	CircoFLEX-MycoFLEX	(BI;	Boehringer	Ingelheim,	St.	Joseph,	MO)	
administered	intramuscularly	at	weaning.	The	other	vaccination	strategy	consisted	of	2	
full	doses	of	Circumvent	and	MYCOSILENCER	(Intervet;	Intervet/Schering-Plough	
Animal	Health,	Millsboro,	DE)	administered	intramuscularly	at	weaning	and	again	22	
d	later.	Both	vaccination	strategies	were	administered	according	to	their	product	label.	
The	BI	vaccination	consisted	of	a	combination	vaccine	that	provided	an	immunization	
for	PCV2	and	Mhyo	with	a	single	2-mL	injection.	The	Intervet	vaccination	required	2	
separate	injections	each	time	of	2	mL	of	Circumvent	and	1	mL	of	MYCOSILENCER	
to	provide	immunization	for	PCV2	and	Mhyo,	respectively.	Prior	to	implementation	of	
PCV2	vaccination	for	all	growing	pigs	at	weaning,	pigs	in	this	production	system	had	
exhibited	severe	clinical	signs	indicative	of	PCVD	that	had	been	confirmed	by	the	histo-
pathologic	evaluation	of	tissues,	and	the	presence	of	PCV2	was	confirmed	by	immuno-
histochemistry.	Subsequent	to	implementation,	these	clinical	signs	had	abated	and	were	
not	apparent	in	the	growing	pig	population	at	the	time	this	trial	was	performed.
At	weaning	(d	0),	all	pigs	were	randomly	placed	in	nursery	pens	in	groups	of	25	pigs.	
Immediately	afterward,	the	pigs	were	individually	weighed,	assigned	a	body	condition	
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score	(BCS;	1	=	emaciated,	2	=	thin,	or	3	=	full-bodied),	and	vaccinated	with	their	
designated	vaccine.	This	resulted	in	the	comingling	of	pigs	from	each	vaccination	treat-
ment	in	all	pens	and	in	all	rooms	throughout	the	study.	On	d	22,	all	pigs	were	weighed	
and	again	assigned	a	BCS.	Also,	pigs	assigned	to	the	Intervet	vaccination	strategy	were	
administered	their	second	dose	of	PCV2	and	Mhyo	vaccines.	During	vaccination,	pigs	
that	exhibited	a	“fainting”	reaction	immediately	after	administration	were	monitored	
and	recorded.	A	“fainting”	reaction	was	defined	as	any	pig	that	was	briefly	unable	to	
stand,	was	immobile,	or	exhibited	involuntary	muscle	contractions	accompanied	by	
interrupted	or	irregular	respiration.	Pigs	were	weighed	and	assigned	a	BCS	again	on		
d	44	and	were	moved	to	a	finishing	barn	at	approximately	74	d	postweaning,	where	they	
were	weighed	again.	Afterward,	all	remaining	pigs	were	weighed	once	more	on	d	156.	
Throughout	the	study,	each	pen	was	equipped	with	a	dry	self-feeder	and	cup	waterer,	
providing	ad	libitum	access	to	feed	and	water.	Pig	removals	and	deaths,	as	well	as	the	
suspected	reasons,	were	recorded	throughout	the	study.	Carcass	data	were	obtained	
from	a	subsample	of	420	pigs	from	one	finisher	room	that	were	harvested	on	a	single	
day	(d	167).
For	data	analysis,	individual	birth	weight	was	used	to	assign	pigs	to	7	birth	weight	cate-
gories,	such	that	each	category	contained	a	roughly	similar	number	of	observations.	The	
genetic	background	and	parity	of	sows	were	confounded,	so	the	effects	of	these	variables	
on	the	performance	of	their	offspring	were	not	evaluated	in	this	experiment.	The	dam	
(litter	of	origin),	nursery	room,	and	finisher	room	were	used	as	random	effects	in	the	
analysis.	Therefore,	vaccination	strategy,	gender,	and	birth	weight	category	were	used	to	
analyze	the	data	as	a	2	×	2	×	7	factorial	arrangement	in	a	completely	randomized	design	
using	the	PROC	MIXED	procedure	of	SAS	(SAS	Institute	Inc.,	Cary,	NC).	Weaning	
age	was	used	as	a	covariate	for	data	analysis.	Individual	pig	was	the	experimental	unit	for	
the	analysis	of	response	criteria.
Results
There	were	no	vaccination	strategy	×	gender	×	birth	weight	category	interactions	
observed	during	the	study.	Therefore,	the	effects	of	vaccination	strategy,	gender	×	
weight	category	interactions,	gender,	and	weight	category	are	reported.
Effects	of	Vaccination	Strategy	on	Subsequent	Growth
From	d	0	to	22,	there	were	no	differences	in	growth	performance	between	the	2	vacci-
nation	strategies	(Table	1).	However,	pigs	vaccinated	with	Intervet	had	a	greater		
(P	<	0.0001)	risk	of	demonstrating	a	“fainting”	reaction	to	vaccination	immediately	
following	injection.	The	“fainting”	reactions	observed	were	not	associated	with	any	
mortality.
Following	the	second	dose	of	Intervet	on	d	22,	ADG	of	pigs	vaccinated	with	BI	was	
greater	(P	<	0.0001)	from	d	22	to	44	than	that	of	pigs	vaccinated	with	Intervet.	This	
resulted	in	improved	(P	<	0.0001)	ADG	from	d	0	to	44	and	d	44	BW	for	pigs	vacci-
nated	with	BI.	There	were	no	differences	in	performance	from	d	44	to	74,	but	pigs	
vaccinated	with	BI	had	greater	(P	<	0.001)	ADG	from	d	0	to	74	and	d	74	BW.
During	the	finishing	period	(d	74	to	156),	pigs	vaccinated	with	Intervet	had	greater	
(P	<	0.05)	ADG	than	those	vaccinated	with	BI.	This	change	in	the	growth	response	
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between	the	2	vaccination	strategies	resulted	in	similar	overall	(d	0	to	156)	growth	
performance.	There	were	no	differences	in	carcass	characteristics,	percentage	of	pigs	less	
than	215	lb,	or	mortality	between	the	2	vaccination	strategies.
Birth	Weight	Category	and	Gender	Interactions
During	the	experiment,	gender	×	weight	category	interactions	were	observed	(P	<	0.03)	
for	ADG	from	d	44	to	74,	percentage	of	culls,	and	percentage	of	pigs	weighing	less	than	
215	lb	on	d	156.	The	ADG	of	barrows	from	d	44	to	74	was	1.43,	1.53,	1.60,	1.69,	1.72,	
1.76,	and	1.68	for	weight	categories	≤	2.5	lb,	2.6	to	3.0	lb,	3.1	to	3.3	lb,	3.4	to	3.6	lb,	
3.7	to	3.9	lb,	4.0	to	4.4	lb,	and	≥	4.5	lb,	respectively.	The	ADG	of	gilts	from	d	44	to	74	
was	1.33,	1.47,	1.51,	1.51,	1.53,	1.54,	and	1.60,	respectively.	The	interaction	occurred	
because	the	rate	of	increase	in	ADG	as	weight	category	increased	was	not	consistent	for	
both	genders.	Despite	the	interaction,	ADG	was	greater	(P	<	0.01)	for	barrows	than	
gilts	and	for	heavier	weight	categories	compared	with	lighter	categories.
The	percentage	of	culls	and	pigs	weighing	less	than	215	lb	for	barrows	was	7.62%,	
7.97%,	4.70%,	3.61%,	4.40%,	1.65%,	and	3.25%	for	weight	categories	≤	2.5	lb,	2.6	to	
3.0	lb,	3.1	to	3.3	lb,	3.4	to	3.6	lb,	3.7	to	3.9	lb,	4.0	to	4.4	lb,	and	≥	4.5	lb,	respectively.	
Percentage	of	culls	and	pigs	weighing	less	than	215	lb	for	gilts	was	27.50%,	13.62%,	
4.52%,	10.97%,	2.05%,	3.21%,	and	0.96%,	respectively.	The	interaction	occurred	
because	the	percentage	of	culls	and	pigs	less	than	215	lb	was	significantly	greater	in	
lighter	weight	categories	for	gilts,	but	the	percentage	of	culls	and	pigs	less	than	215	lb	
was	similar	for	barrows	and	gilts	in	heavier	weight	categories.	In	spite	of	the	interac-
tion,	the	percentage	of	culls	and	pigs	weighing	less	than	215	lb	was	less	(P	<	0.001)	for	
barrows	and	pigs	of	heavier	weight	categories.
The	Effects	of	Birth	Weight	Category	on	Subsequent	Growth
As	expected,	birth	weight	increased	(P	<	0.0001)	as	weight	category	increased.	Also,	
preweaning	ADG,	weaning	weight,	and	BCS	at	weaning	were	improved	(P	<	0.0001)	
for	pigs	as	weight	category	increased	(Table	2).
After	weaning,	pigs	in	increasing	weight	categories	had	improved	(P	<	0.0001)	ADG	
and	final	BW	for	all	periods	(d	0	to	22,	d	22	to	44,	d	0	to	44,	d	44	to	74,	d	0	to	74,	d	74	
to	156,	and	d	0	to	156).	Postweaning	mortality	was	not	affected	by	weight	category.	
Pigs	of	heavier	weight	categories	also	had	greater	(P	<	0.0001)	HCW	compared	with	
lighter	weight	category	pigs.	However,	there	were	no	differences	in	the	backfat	depth,	
loin	depth,	and	fat-free	lean	of	pigs	subsampled	from	the	different	weight	categories	in	
this	experiment.
The	Effects	of	Gender	on	Subsequent	Growth
From	d	0	to	22,	ADG,	d	22	BW,	and	d	22	BCS	were	greater	(P	<	0.01)	for	gilts	than	for	
barrows	(Table	3).	Although	there	were	no	differences	in	ADG	from	d	22	to	44	or	d	44	
BW,	there	was	a	tendency	for	(P	<	0.06)	gilts	to	have	greater	ADG	from	d	0	to	44.
However,	for	d	44	to	74	and	the	entire	nursery	period	(d	0	to	74),	ADG	and	d	74	BW	
were	improved	(P	<	0.001)	for	barrows.	The	ADG	of	barrows	was	also	greater	
(P	<	0.0001)	during	the	finishing	period	(d	74	to	156)	than	that	of	gilts.
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Overall	(d	0	to	156),	ADG,	final	BW,	HCW,	and	backfat	depth	of	barrows	were	
increased	(P	<	0.0001),	whereas	the	percentage	fat-free	lean	was	reduced	(P	<	0.0001)	
compared	with	gilts.	Postweaning	mortality	of	barrows	and	gilts	was	not	significantly	
different.
Discussion
Although	there	was	not	an	unvaccinated	control	group	in	the	current	experiment,	
the	differences	observed	between	the	2	vaccination	strategies	are	similar	to	previous	
nursery	experiments	(Kane	et	al.,	2008;	Potter	et	al.,	20096;	Shelton	et	al.,	20097).	Pigs	
vaccinated	in	the	current	experiment	with	Intervet	on	d	0	and	22	experienced	a	tran-
sient	reduction	in	growth	after	administration	of	the	second	dose.	Kane	et	al.	(2008)	
reported	a	transient	reduction	in	growth	after	a	single	dose	of	Circumvent,	but	the	pigs	
in	their	experiment	were	primarily	maternal-line	(PIC	1050)	barrows,	considerably	
lighter	at	weaning,	and	vaccinated	with	Respisure	1	(Pfizer	Animal	Health,	New	York,	
NY)	at	the	same	time.	Potter	et	al.	(2009)	observed	similar	differences	in	the	growth	
of	pigs	vaccinated	with	2	doses	of	Circumvent	and	1	dose	of	CircoFLEX	as	in	the	
current	experiment.	It	is	unclear	whether	the	growth	of	pigs	vaccinated	with	BI	in	the	
current	experiment	was	affected	by	vaccination,	but	Potter	et	al.	(2009)	did	not	observe	
any	differences	in	nursery	growth	between	pigs	vaccinated	with	CircoFLEX	and	the	
controls.
In	spite	of	the	negative	effect	of	the	Intervet	vaccination	strategy	on	nursery	perfor-
mance,	the	growth	of	these	pigs	in	the	finisher	was	better	than	that	of	pigs	vaccinated	
using	the	BI	strategy.	As	a	result,	overall	performance	was	not	different	between	the	2	
vaccination	strategies.	Although	clinical	PCVD	was	not	noted	in	any	of	the	growing	
pig	groups,	this	suggests	that	the	Intervet	strategy	may	have	provided	more	effective	
immunity	during	the	finisher	phase,	which	led	to	better	growth	performance.	The	end	
result	was	the	same,	but	the	similar	efficacy	of	the	two	vaccination	strategies	is	worthy	
of	further	investigation.
These	data	demonstrate	the	importance	of	increasing	birth	weight	for	improving	the	
lifetime	growth	performance	of	pigs	(Figures	1	and	2).	Although	identifying	differ-
ences	in	preweaning	mortality	between	birth	weight	categories	was	not	undertaken	for	
this	report,	it	is	apparent	that	management	strategies	to	increase	the	birth	weight	and	
growth	performance	of	the	lightest	30%	of	pigs	born	may	be	beneficial.
The	overall	differences	in	growth	and	carcass	characteristics	between	barrows	and	gilts	
were	typical	and	not	unexpected.	These	data	reinforce	the	potential	need	for	differing	
management	strategies	to	optimize	the	performance	of	barrows	and	gilts	within	a	popu-
lation	(e.g.,	split-sex	feeding,	different	pig	flows,	different	feeders,	etc.).	Although	there	
were	no	differences	in	postweaning	mortality,	the	slower	overall	growth	rate	of	gilts	
resulted	in	twice	as	many	gilts	being	culled	for	weight	than	barrows.	This	was	particu-
larly	problematic	for	the	gilts	in	this	study	that	had	a	birth	weight	≤	2.5	lb.	These	gilts	
were	nearly	4	times	more	likely	to	be	culled	because	of	poor	growth	rate	than	barrows	of	
similar	birth	weight.
6	Potter	et	al.,	Swine	Day	2009,	Report	of	Progress	1020,	pp.	21-27.
7	Shelton	et	al.,	Swine	Day	2009,	Report	of	Progress	1020,	pp.	28-XX.
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In	conclusion,	vaccinating	pigs	for	PCV2	and	Mhyo	with	different	vaccination	strate-
gies	resulted	in	differences	in	growth	rate	in	the	nursery	and	finishing	phases	but	equal	
performance	overall.	These	data	also	illustrate	the	biological	differences	in	growth	
among	pigs	of	differing	birth	weights	and	between	barrows	and	gilts.	A	greater	under-
standing	of	these	differences,	and	the	implementation	of	management	strategies	to	miti-
gate	their	effects,	may	result	in	significant	improvements	in	overall	performance.	
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Table 1. Effect of PCV2 and Mhyo vaccine strategy on growth and carcass characteristics of pigs1
Growth	performance
PCV2	and	Mhyo	vaccination	strategy2
SEM Probability,	P	<BI Intervet
Pigs,	no. 1,006 989
Preweaning	ADG,	lb3 0.52 0.52 0.01 ---4
Initial	birth	wt,	lb 3.51 3.50 0.01 ---
Weaning	age,	d 25.10 25.05 0.44 ---
ADG,	lb
					d	0	to	d	22 0.74 0.74 0.03 ---
					d	22	to	44 1.43 1.36 0.07 0.0001
					d	0	to	d	44 1.09 1.05 0.02 0.0001
					d	44	to	74 1.58 1.56 0.04 ---
					d	0	to	d	74 1.28 1.25 0.02 0.001
					d	74	to	156 1.89 1.92 0.03 0.05
					d	0	to	156 1.61 1.61 0.02 ---
Pig	weight,	lb
					Weaning	(d	0) 16.54 16.49 0.15 ---
					d	22 32.69 32.54 2.68 ---
					d	44 63.71 61.97 3.55 0.0001
					d	74 111.06 108.73 3.33 0.001
					d	156 268.21 267.88 5.79 ---
Body	condition	score5
					d	0 2.86 2.86 0.02 ---
					d	22 2.98 2.99 0.01 ---
					d	44 3.00 3.00 0.01 ---
“Fainting”	reaction,	% 0.00 1.58 0.29 0.0001
Cull	and	<	215	lb	BW,	% 6.80 6.80 1.50 ---
Postweaning	mortality,	% 1.67 1.46 0.41 ---
Carcass	characteristics6
					Pigs,	no. 213 205
					Final	BW	(181	d	of	age),	lb 267.7 270.3 2.88 ---
					HCW	(192	d	of	age),	lb 206.8 208.9 1.97 ---
					Backfat	depth,	mm 17.46 18.13 0.38 ---
					Loin	depth,	mm 56.78 57.66 0.53 ---
					Fat-free	lean,	% 52.22 51.91 0.24 ---
1	A	total	of	1,995	pigs	were	used	to	evaluate	the	effects	of	PCV2	and	Mhyo	vaccine	strategy	on	pig	performance	and	carcass	
characteristics.
2	PCV2	and	Mhyo	vaccine	strategies	tested	were:	BI,	a	single	full	dose	of	CircoFLEX-MycoFLEX	at	d	0,	and	Intervet,	a	full	dose	
of	Circumvent	and	MYCOSILENCER	at	d	0	and	22.
3	Results	are	reported	as	least	squares	means.
4	Probability,	P	>	0.10.
5	1	=	emaciated,	2	=	thin,	or	3	=	full-bodied.
6	Carcass	data	were	obtained	from	a	subsample	of	420	pigs	harvested	in	a	single	day	(d	167	postweaning).
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Table 3. Effect of gender on growth and carcass characteristics of pigs1
Growth	performance
Gender
SEM Probability,	P	<Barrows Gilts
Pigs,	no. 980 1,015
Preweaning	ADG,	lb2 0.52 0.52 0.01 ---3
Initial	birth	wt,	lb 3.51 3.50 0.01 ---
Weaning	age,	d 25.09 25.06 0.44 ---
ADG,	lb
					d	0	to	d	22 0.73 0.76 0.03 0.0001
					d	22	to	44 1.40 1.39 0.07 ---
					d	0	to	d	44 1.06 1.08 0.02 0.06
					d	44	to	74 1.63 1.50 0.04 0.0001
					d	0	to	d	74 1.29 1.25 0.02 0.0001
					d	74	to	156 2.02 1.80 0.03 0.0001
					d	0	to	156 1.68 1.54 0.02 0.0001
Pig	weight,	lb
					Weaning	(d	0) 16.49 16.54 0.15 ---
					d	22 32.24 32.99 2.68 0.01
					d	44 62.49 63.19 3.55 ---
					d	74 111.44 108.35 3.33 0.0001
					d	156 278.87 257.22 5.79 0.0001
Body	condition	score4
					d	0 2.87 2.86 0.02 ---
					d	22 2.98 2.99 0.01 0.01
					d	44 3.00 3.00 0.01 ---
Cull	and	<	215	lb	BW,	% 4.60 8.90 1.50 0.001
Postweaning	mortality,	% 1.73 1.40 0.41 ---
Carcass	characteristics5
					Pigs,	no. 203 217
					Final	BW	(181	d	of	age),	lb 279.33 258.65 2.87 0.0001
					HCW	(192	d	of	age),	lb 215.04 200.65 1.95 0.0001
					Backfat	depth,	mm 19.66 15.93 0.38 0.0001
					Loin	depth,	mm 57.04 57.41 0.53 ---
					Fat-free	lean,	% 50.90 53.23 0.24 0.0001
1	A	total	of	1,995	pigs	were	used	to	evaluate	the	effects	of	gender	on	pig	performance	and	carcass	characteristics.
2	Results	are	reported	as	least	squares	means.
3	Probability,	P	>	0.10.
4	1	=	emaciated,	2	=	thin,	or	3	=	full-bodied.
5	Carcass	data	were	obtained	from	a	subsample	of	420	pigs	harvested	in	a	single	day	(d	167	postweaning).
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